Aridis Pharmaceuticals, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 1.20%165.510.7%$1174.18m
PFEPfizer Inc. 1.48%37.090.9%$1154.88m
LLYEli Lilly & Co. 2.35%210.981.1%$955.68m
ABBVAbbVie, Inc. -0.32%110.501.9%$729.77m
BMYBristol-Myers Squibb Co. 0.14%64.651.0%$680.15m
MRKMerck & Co., Inc. 0.06%81.030.7%$678.46m
AZNAstraZeneca Plc 1.04%53.801.2%$676.66m
ARCTArcturus Therapeutics Holdings, Inc. 0.81%68.250.0%$231.84m
VTRSViatris, Inc. -1.23%17.220.0%$191.23m
GRTSGritstone Oncology, Inc. -11.99%23.860.0%$185.75m
RPRXRoyalty Pharma Plc 1.25%51.800.2%$176.45m
NVSNovartis AG 1.22%98.080.2%$176.09m
GSKGlaxoSmithKline Plc 1.45%38.920.2%$156.67m
SNYSanofi -0.38%49.500.2%$134.46m
RGENRepligen Corp. -1.66%215.686.9%$77.09m

Company Profile

Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-105, AR-101, AR-401, AR-201, and AR-501. The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in Los Gatos, CA.